These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 11805133)

  • 1. Heparin cofactor II inhibits arterial thrombosis after endothelial injury.
    He L; Vicente CP; Westrick RJ; Eitzman DT; Tollefsen DM
    J Clin Invest; 2002 Jan; 109(2):213-9. PubMed ID: 11805133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombotic activity of dermatan sulfate in heparin cofactor II-deficient mice.
    Vicente CP; He L; Pavão MS; Tollefsen DM
    Blood; 2004 Dec; 104(13):3965-70. PubMed ID: 15315969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular dermatan sulfate and heparin cofactor II.
    Tollefsen DM
    Prog Mol Biol Transl Sci; 2010; 93():351-72. PubMed ID: 20807652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accelerated atherogenesis and neointima formation in heparin cofactor II deficient mice.
    Vicente CP; He L; Tollefsen DM
    Blood; 2007 Dec; 110(13):4261-7. PubMed ID: 17878401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular dermatan sulfate regulates the antithrombotic activity of heparin cofactor II.
    He L; Giri TK; Vicente CP; Tollefsen DM
    Blood; 2008 Apr; 111(8):4118-25. PubMed ID: 18281504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin cofactor II modulates the response to vascular injury.
    Tollefsen DM
    Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):454-60. PubMed ID: 17194895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin cofactor II as a novel vascular protective factor against atherosclerosis.
    Aihara K; Azuma H; Akaike M; Sata M; Matsumoto T
    J Atheroscler Thromb; 2009 Oct; 16(5):523-31. PubMed ID: 19729870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Heparin cofactor II, a thrombin inhibitor with a still not clarified physiologic role].
    Rossi EB; Duboscq CL; Kordich LC
    Medicina (B Aires); 1999; 59(1):95-104. PubMed ID: 10349131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin cofactor II: discovery, properties, and role in controlling vascular homeostasis.
    Rau JC; Mitchell JW; Fortenberry YM; Church FC
    Semin Thromb Hemost; 2011 Jun; 37(4):339-48. PubMed ID: 21805439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strain-dependent embryonic lethality and exaggerated vascular remodeling in heparin cofactor II-deficient mice.
    Aihara K; Azuma H; Akaike M; Ikeda Y; Sata M; Takamori N; Yagi S; Iwase T; Sumitomo Y; Kawano H; Yamada T; Fukuda T; Matsumoto T; Sekine K; Sato T; Nakamichi Y; Yamamoto Y; Yoshimura K; Watanabe T; Nakamura T; Oomizu A; Tsukada M; Hayashi H; Sudo T; Kato S; Matsumoto T
    J Clin Invest; 2007 Jun; 117(6):1514-26. PubMed ID: 17549254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin cofactor II attenuates vascular remodeling in humans and mice.
    Aihara K
    Circ J; 2010 Aug; 74(8):1518-23. PubMed ID: 20671370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin cofactor II is a novel protective factor against carotid atherosclerosis in elderly individuals.
    Aihara K; Azuma H; Takamori N; Kanagawa Y; Akaike M; Fujimura M; Yoshida T; Hashizume S; Kato M; Yamaguchi H; Kato S; Ikeda Y; Arase T; Kondo A; Matsumoto T
    Circulation; 2004 Jun; 109(22):2761-5. PubMed ID: 15148272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased heparin cofactor II activity is associated with impaired endothelial function determined by brachial ultrasonography and predicts cardiovascular events.
    Huang PH; Leu HB; Chen JW; Wu TC; Lu TM; Yu-An Ding P; Lin SJ
    Int J Cardiol; 2007 Jan; 114(2):152-8. PubMed ID: 16650906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine heparin cofactor II: purification, cDNA sequence, expression, and gene structure.
    Zhang GS; Mehringer JH; Van Deerlin VM; Kozak CA; Tollefsen DM
    Biochemistry; 1994 Mar; 33(12):3632-42. PubMed ID: 7908224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and cellular basis for type I heparin cofactor II deficiency (heparin cofactor II Awaji).
    Kondo S; Tokunaga F; Kario K; Matsuo T; Koide T
    Blood; 1996 Feb; 87(3):1006-12. PubMed ID: 8562924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of frog and chicken cDNAs encoding heparin cofactor II.
    Colwell NS; Tollefsen DM
    Thromb Haemost; 1998 Nov; 80(5):784-90. PubMed ID: 9843172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin cofactor II protects against angiotensin II-induced cardiac remodeling via attenuation of oxidative stress in mice.
    Sumitomo-Ueda Y; Aihara K; Ise T; Yoshida S; Ikeda Y; Uemoto R; Yagi S; Iwase T; Ishikawa K; Hirata Y; Akaike M; Sata M; Kato S; Matsumoto T
    Hypertension; 2010 Sep; 56(3):430-6. PubMed ID: 20660821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin cofactor II determination--levels in normals and patients with hereditary antithrombin III deficiency and disseminated intravascular coagulation.
    Tran TH; Duckert F
    Thromb Haemost; 1984 Oct; 52(2):112-6. PubMed ID: 6395434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of antithrombin and heparin cofactor II levels on anticoagulation with Intimatan.
    Tanaka KA; Szlam F; Vinten-Johansen J; Cardin AD; Levy JH
    Thromb Haemost; 2005 Oct; 94(4):808-13. PubMed ID: 16270635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of heparin cofactor II in the modulation of hemostasis.
    Salem HH; Thompson EA
    Dev Biol Stand; 1987; 67():67-72. PubMed ID: 3301469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.